High-Bioactivity Goat Colostrum Powder Preparation Method

ChangeBridge: Patent Apps - Pharma (A61K)

Published October 22nd, 2024

Detected March 26th, 2026

Summary

The USPTO has published a patent application detailing a method for preparing a high-bioactivity goat colostrum composite freeze-dried powder. The invention focuses on enhancing the stability and survival rate of probiotics within the powder through encapsulation techniques.

View original document View source feed page

What changed

This document is a patent application (US20260083675A1) filed with the USPTO, describing a novel preparation method for a high-bioactivity goat colostrum composite freeze-dried powder. The method involves specific ratios of goat colostrum powder, composite probiotic liposome freeze-dried powder, and mannose oligosaccharides. Key to the invention is the preparation of modified phytosterol and chitosan to encapsulate probiotics, thereby protecting them and improving their survival rate.

This patent application does not impose immediate regulatory obligations on companies. However, it signifies potential innovation in the food and pharmaceutical sectors related to probiotic stability and delivery. Companies involved in developing or manufacturing probiotic supplements or functional foods may find this technology relevant for future product development or licensing opportunities. Compliance officers should note this as a development in the intellectual property landscape for such products.

Source document (simplified)

← USPTO Patent Applications

HIGH-BIOACTIVITY GOAT COLOSTRUM COMPOSITE FREEZE-DRIED POWDER AND PREPARATION METHOD THEREOF

Application US20260083675A1 Kind: A1 Mar 26, 2026

Inventors

Boxing Chen, Lei Zhang

Abstract

A high-bioactivity goat colostrum composite freeze-dried powder relates to the technical field of food, comprising the following components in parts by weight: 60-70 parts of goat colostrum powder, 5-8 parts of composite probiotic liposome freeze-dried powder, and 6-9 parts of mannose oligosaccharides; the composite probiotic liposome freeze-dried powder is prepared from the following components: gallic acid, phytosterol, soybean phosphatidylcholine, modified chitosan, and probiotic powder; the probiotic powder is Bifidobacterium longum powder or Lactobacillus acidophilus powder. The invention proposes to prepare modified phytosterol by esterification reaction of gallic acid and phytosterol, and to prepare probiotic liposomes by encapsulating probiotics with the modified phytosterol and soybean phosphatidylcholine, and at the same time introduce carboxymethyl into chitosan to prepare modified chitosan, and to prepare composite probiotic liposome freeze-dried powder by encapsulating probiotic liposomes with the modified chitosan, thereby protecting probiotics, thereby reducing the inactivation of probiotics, and improving their survival rate.